Stereoselective Block of hERG Channel by (S)‐Methadone and QT Interval Prolongation in CYP2B6 Slow Metabolizers

[1]  C. Katlama,et al.  Drug interactions between antineoplastic and antiretroviral therapies: Implications and management for clinical practice. , 2009, Critical reviews in oncology/hematology.

[2]  R. Walsky,et al.  Evaluation of 227 Drugs for In Vitro Inhibition of Cytochrome P450 2B6 , 2006, Journal of clinical pharmacology.

[3]  C. Eap,et al.  ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment , 2006, Clinical pharmacology and therapeutics.

[4]  D. Shah,et al.  Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors. , 2006, Archives of internal medicine.

[5]  R. D. Bruce,et al.  Pharmacokinetic Drug Interactions Between Opioid Agonist Therapy and Antiretroviral Medications: Implications and Management for Clinical Practice , 2006, Journal of acquired immune deficiency syndromes.

[6]  C. Eap,et al.  Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment , 2005, Clinical pharmacology and therapeutics.

[7]  M. Eichelbaum,et al.  Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz , 2005, Pharmacogenetics and genomics.

[8]  R. Woosley,et al.  QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system , 2005, Pharmacoepidemiology and drug safety.

[9]  Nicole Schmitt,et al.  Local Anesthetic Interaction with Human Ether-a-go-go–related Gene (HERG) Channels: Role of Aromatic Amino Acids Y652 and F656 , 2005, Anesthesiology.

[10]  C. January,et al.  Intragenic Suppression of Trafficking-Defective KCNH2 Channels Associated with Long QT Syndrome , 2005, Molecular Pharmacology.

[11]  C. Sticherling,et al.  Methadone-induced Torsade de pointes tachycardias. , 2005, Swiss medical weekly.

[12]  P. Tarantino,et al.  Effect of trazodone on hERG channel current and QT-interval. , 2005, European journal of pharmacology.

[13]  Michael C Sanguinetti,et al.  Predicting drug-hERG channel interactions that cause acquired long QT syndrome. , 2005, Trends in pharmacological sciences.

[14]  T. Buclin,et al.  Molecular and clinical determinants of drug-induced long QT syndrome: an iatrogenic channelopathy. , 2004, Swiss medical weekly.

[15]  E. Kharasch,et al.  Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone , 2004, Clinical pharmacology and therapeutics.

[16]  P. Dayer,et al.  QT interval prolongation in patients on methadone with concomitant drugs. , 2004, Journal of clinical psychopharmacology.

[17]  J. Gerber,et al.  Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19. , 2004, Chirality.

[18]  M. Eichelbaum,et al.  CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real‐rime PCR , 2003, Human mutation.

[19]  F. Segura,et al.  QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone. , 2003, The American journal of cardiology.

[20]  H. Thaler,et al.  QTc interval prolongation associated with intravenous methadone , 2003, Pain.

[21]  Evan Mokwe,et al.  Torsade de pointes due to methadone. , 2003, Annals of internal medicine.

[22]  P. Walker,et al.  High dose methadone and ventricular arrhythmias: a report of three cases , 2003, Pain.

[23]  D. De Bels,et al.  Torsades de pointes due to methadone. , 2003, Annals of internal medicine.

[24]  I. Anguera,et al.  Torsade de pointes due to methadone. , 2003, Annals of internal medicine.

[25]  J. Tamargo,et al.  Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: stereoselective bupivacaine block , 2002, British journal of pharmacology.

[26]  A. Katchman,et al.  Influence of Opioid Agonists on Cardiac HumanEther-a-go-go-related Gene K+ Currents , 2002, Journal of Pharmacology and Experimental Therapeutics.

[27]  P. Mehler,et al.  Torsade de Pointes Associated with Very-High-Dose Methadone , 2002, Annals of Internal Medicine.

[28]  T. Buclin,et al.  Interindividual Variability of the Clinical Pharmacokinetics of Methadone , 2002, Clinical pharmacokinetics.

[29]  J. Caldwell.  Do single enantiomers have something special to offer? , 2001, Human psychopharmacology.

[30]  U. Hofmann,et al.  Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. , 2001, Pharmacogenetics.

[31]  A. Gorman,et al.  The d- and l- isomers of methadone bind to the non-competitive site on the N-methyl-d-aspartate (NMDA) receptor in rat forebrain and spinal cord , 1997, Neuroscience Letters.

[32]  A. Molven,et al.  Ultrarapid metabolizers of debrisoquine: Characterization and PCR‐based detection of alleles with duplication of the CYP2D6 gene , 1996, FEBS letters.

[33]  R. Shank,et al.  Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. , 1995, The Journal of pharmacology and experimental therapeutics.

[34]  M. Sanguinetti,et al.  A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.

[35]  P. Krogsgaard‐Larsen,et al.  Ketobemidone, methadone and pethidine are non-competitive N-methyl-d-aspartate (NMDA) antagonists in the rat cortex and spinal cord , 1995, Neuroscience Letters.

[36]  L. Christrup,et al.  The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. , 1995, Life sciences.

[37]  L. Christrup,et al.  Pharmacology letterThe mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine , 1994 .

[38]  W. P. Gordon,et al.  Seminal excretion, vaginal absorption, distribution and whole blood kinetics of d-methadone in the rabbit. , 1978, The Journal of pharmacology and experimental therapeutics.

[39]  H. Sullivan,et al.  Urinary metabolites of dl-methadone in maintenance subjects. , 1973, Journal of medicinal chemistry.

[40]  R. Bloch,et al.  Physiological disposition and metabolism of levo-methadone-1- 3 H in nontolerant and tolerant rats. , 1973, The Journal of pharmacology and experimental therapeutics.

[41]  J. Bogdanowicz,et al.  REPORT OF THREE CASES. , 1963, American journal of diseases of children.

[42]  G. A. Drew.  HENS THAT HAVE LAID TWO EGGS IN A DAY. , 1907, Science.